This inventor holds 14 USPTO granted patents and 10 published patent applications and 6 EPO patents, primarily in Macrocyclic Compounds. Top assignees: Turning Point Therapeutics, Inc., Tp Therapeutics, Inc.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Areas of Expertise:
Title: Innovator in Macrocyclic Compounds: The Contributions of Wei Deng
Introduction
Wei Deng, an accomplished inventor based in San Diego, CA, has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel macrocyclic compounds. With an impressive portfolio of 13 patents, his innovative work focuses on addressing critical health issues through cutting-edge research and applications.
Latest Patents
Among Wei Deng's latest patents are two notable inventions:
1. **Chiral Diaryl Macrocycles and Uses Thereof** - This patent outlines the use of specific diaryl macrocycle compounds, particularly (7S13R)-11-fluoro-7,13-di-methyl-6,7,13,14-tetrahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one, which shows potential in treating diseases in mammals, with a particular emphasis on human applications.
2. **Macrocyclic Compounds and Uses Thereof** - This disclosure focuses on certain macrocyclic compounds that inhibit key cancer-related proteins such as SRC, MET, and CSFR. It details pharmaceutical compositions containing these innovative compounds and the methods for utilizing them in cancer treatment.
Career Highlights
Throughout his career, Wei Deng has been associated with prominent organizations that are at the forefront of therapeutic development. Notable companies include Turning Point Therapeutics, Inc. and Tp Therapeutics, Inc. His expertise in macrocyclic compounds has positioned him as a leader in the quest for solutions to challenging medical conditions.
Collaborations
Wei Deng has collaborated with talented professionals in his field, enhancing his innovative contributions. Some of his noteworthy colleagues include Jingrong Jean Cui and Dayong Zhai, whose collective efforts contribute to advancing the science behind their inventions.
Conclusion
Wei Deng's remarkable achievements in the realm of macrocyclic compound research highlight his dedication to innovation and the betterment of healthcare. With a total of 13 patents, his work not only demonstrates his expertise but also reflects the potential to significantly impact the treatment of various diseases. As he continues to explore new frontiers in pharmaceutical chemistry, the implications of his inventions will remain vital in the fight against challenging health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile